Skip to content

Clinical trials

Phase 2/3 Generalized Anxiety Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 2/3 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20071
20101
20121
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pittsburgh2
Bristol-Myers Squibb1
National Center for Complementary and Integrative Health (NCCIH)1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
University of South Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder6
Anxiety Disorders4
Panic Disorder2
Phobia, Social2
Anxiety, Separation1
Asperger Syndrome1
Autistic Disorder1
Obsessive-Compulsive Disorder1

Trials

Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.